Ani Pharmaceuticals Inc. (ANIP)
NASDAQ · Healthcare
Ani Pharmaceuticals Inc. Revenue 2009–2025
Ani Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ani Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 237.5 M, a 20.46% increase year-over-year.
- Ani Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 873.8 M, a 57.26% increase year-over-year.
- Ani Pharmaceuticals Inc. annual revenue for 2025 was 883.4 M, a 43.78% increase from 2024.
- Ani Pharmaceuticals Inc. annual revenue for 2024 was 614.4 M, a 26.20% increase from 2023.
- Ani Pharmaceuticals Inc. annual revenue for 2023 was 486.8 M, a 53.87% increase from 2022.
- Ani Pharmaceuticals Inc. annual revenue for 2022 was 316.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ani Pharmaceuticals Inc. Market Cap — FAQ
Ani Pharmaceuticals Inc. (ANIP) market cap over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANIP's market cap history?
The chart and table above show Ani Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.